Seeking Alpha

Neoprobe (NEOP -10.2%) fell sharply in afternoon trading on rumors an application for its...

Neoprobe (NEOP -10.2%) fell sharply in afternoon trading on rumors an application for its Lymphoseek cancer-detection drug was rejected. However, shares are up 5.8% AH after a spokesperson says Neoprobe isn't aware of any news about its application, which the FDA is expected to decide upon by Oct. 24.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)